benzoyl peroxide · Mayne Pharma · NDA 214510
Epsolay
Earliest generic entry, as listed
23 May 2041
Blocked by patent: US 12257348.
Listed patents · 14 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12257348 | drug product, use U-3947 · sets the listed date | 23 May 2041 |
| US 11628155 | use U-3356 | 27 Dec 2040 |
| US 12295935 | use U-3356 | 27 Dec 2040 |
| US 11426378 | use U-3356 | 18 Aug 2040 |
| US 10933046 | drug product, use U-3357 | 19 Feb 2040 |
| US 10945987 | use U-3356 | 19 Feb 2040 |
| US 11541026 | use U-3356 | 19 Feb 2040 |
| US 11865100 | use U-3357 | 19 Feb 2040 |
| US 11877997 | use U-3356 | 19 Feb 2040 |
| US 11986456 | use U-3947 | 19 Feb 2040 |
| US 9687465 | drug product, use U-3356 | 27 Nov 2032 |
| US 9868103 | drug product, use U-3356 | 8 Aug 2028 |
| US 12156946 | drug product | 3 Feb 2028 |
| US 12350382 | drug product | 3 Feb 2028 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 214510 · 001 · RLD | cream, topical | 5% | 23 May 2041 |